Literature DB >> 18346227

National Institute of Neurological Disorders and Stroke (NINDS): advances in understanding and treating neuropathy, 24-25 October 2006; Bethesda, Maryland.

Eva L Feldman1, David R Cornblath, John Porter, Robert Dworkin, Steven Scherer.   

Abstract

National Institute of Neurological Disorders and Stroke sponsored a meeting to explore the current status of basic and clinical research in peripheral neurobiology and clinical neuropathy. The goal of the workshop was to identify areas where additional research could lead to the development of new therapeutics in the next 5 years. Participants discussed the current understanding of disease mechanisms of axonal and demyelinating neuropathies, existing techniques in research, disease biomarkers, and assessment of neuropathy. Painful neuropathies were discussed at the basic scientific and clinical levels in relation to new insights into etiology and treatment. The meeting concluded with a discussion on therapeutic development in neuropathy and the need for a unified approach to multicenter trials. Short-term goals of the workshop were to form a working group for neuropathy, the Peripheral Neuropathy Study Group, and to translate new scientific findings into therapies and complete clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18346227      PMCID: PMC2680078          DOI: 10.1111/j.1529-8027.2008.00154.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  3 in total

1.  NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.

Authors:  Elena G Zotova; Joseph C Arezzo
Journal:  Physiol J       Date:  2013

2.  Effectiveness of low-power laser therapy in improvement of the peripheral neuropathy induced by xenobiotics in rats.

Authors:  Fathia Abd Elwahid Mannaa; Khaled Gamal El-Deen Abdel-Wahhab; Eitedal Mahmoud Daoud; Aliaa Abdel Rahman El Gendy; Maha Mohamed Saber; Nevein Naim Fadl
Journal:  Biochem Biophys Rep       Date:  2021-07-26

3.  Switching myelination on and off.

Authors:  James L Salzer
Journal:  J Cell Biol       Date:  2008-05-19       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.